Puche-Juarez María, Toledano Juan M, Moreno-Fernandez Jorge, Diaz-Castro Javier, Sánchez-Romero Javier, Mar Gil María, Rolle Valeria, Nieto-Díaz Aníbal, Ochoa Julio J, De Paco Matallana Catalina
Department of Physiology, Faculty of Pharmacy, Campus Universitario de Cartuja, University of Granada, 18071 Granada, Spain.
Institute of Nutrition and Food Technology "José Mataix Verdú", Biomedical Research Centre, University of Granada, 18016 Armilla, Spain.
Antioxidants (Basel). 2025 Mar 8;14(3):324. doi: 10.3390/antiox14030324.
Twin pregnancies, with higher incidences of preterm birth, are becoming more prevalent. Progesterone has shown effectiveness in the prevention of preterm labour, though other factors related to pregnancy and neonatal health may be affected by this hormone and have not been previously addressed. This study aims to evaluate the impact of progesterone administration on oxidative stress and bone turnover during twin gestation and investigate associations with some maternal/neonatal variables of interest. Women pregnant with twins were recruited in the "Virgen de la Arrixaca" University Hospital and randomly assigned to two groups: control (n = 49) and progesterone (n = 50). A total of 600 mg/day of progesterone was vaginally administered from 11 to 14 to 34 weeks of gestation. Blood samples were taken in the first (T1) and third trimester (T3), analyzing biomarkers related to oxidative stress and bone turnover. Most bone turnover and oxidative markers experiment with significant changes during gestation. Progesterone administration significantly increased ( < 0.05) the levels of osteocalcin in T3 and decreased ( < 0.05) the levels of sclerostin. Regarding oxidative stress, the progesterone group, unlike the control group, showed no significant increase in oxidative stress between T1 and T3. In conclusion, results show that progesterone administration could increase maternal bone formation and modulate oxidative stress.
双胎妊娠早产发生率较高,且越来越普遍。孕酮已显示出在预防早产方面的有效性,不过与妊娠和新生儿健康相关的其他因素可能会受到这种激素的影响,且此前尚未得到探讨。本研究旨在评估在双胎妊娠期间给予孕酮对氧化应激和骨转换的影响,并调查其与一些感兴趣的母体/新生儿变量之间的关联。在“Virgen de la Arrixaca”大学医院招募了双胎妊娠女性,并将其随机分为两组:对照组(n = 49)和孕酮组(n = 50)。从妊娠11至14周直至34周,每天经阴道给予总共600毫克孕酮。在孕早期(T1)和孕晚期(T3)采集血样,分析与氧化应激和骨转换相关的生物标志物。大多数骨转换和氧化标志物在妊娠期间会发生显著变化。给予孕酮显著增加了(<0.05)T3期骨钙素水平,并降低了(<0.05)硬化蛋白水平。关于氧化应激,与对照组不同,孕酮组在T1和T3之间氧化应激没有显著增加。总之,结果表明给予孕酮可增加母体骨形成并调节氧化应激。